Could a week of antibiotics stop joint infections after replacement surgery?

NCT ID NCT04297592

ENROLLING_BY_INVITATION Disease control Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether taking a 7-day course of oral antibiotics after hip or knee replacement surgery can prevent joint infections in patients at higher risk due to conditions like obesity, diabetes, or autoimmune disease. About 4,600 participants will receive one of three antibiotics (cephalexin, doxycycline, or cefadroxil) or a placebo. The goal is to see if this simple preventive step reduces infections and wound complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cephalexin, Doxycycline, or Cefadroxil
What this could lead to
If effective, a short course of oral antibiotics could reduce the risk of serious joint infections after hip or knee replacement in people with conditions like diabetes or obesity.
What could go wrong
This is a Phase 4 trial, so the drugs are already approved, but the specific benefit in this high-risk group is unproven. Antibiotics can cause side effects like allergic reactions or diarrhea, and overuse may contribute to antibiotic resistance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55902, United States

  • University of Iowa Hospitals & Clinics

    Iowa City, Iowa, 52242, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.